[Radio-hormonal study (radioimmunoassay) in young women with functional hyperprolactinemia. 2) Effects of a dopaminergic agonist, ibopamine, on the regulation of prolactin and gonadotropin secretion (LH, FSH)].
D000262:Adenylyl Cyclases / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D003846:Deoxyepinephrine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004298:Dopamine / Q000031:analogs & derivatives*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D006966:Hyperprolactinemia / Q000097:blood / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000097:blood; D011388:Prolactin / Q000097:blood; D011956:Receptors, Cell Surface / Q000032:analysis; D011966:Receptors, LHRH
D011956:Receptors, Cell Surface; D011966:Receptors, LHRH; C023487:ibopamine; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D000262:Adenylyl Cyclases; D003846:Deoxyepinephrine; D004298:Dopamine
Studio radioormonale (R.I.A.) in giovani donne con iperprolattinemia funzionale. 2) Effetti di un agonista dopaminergico, la ibopamina, sulla regolazione di prolattina (PRL) e sulla secrezione di gonadotropine (LH, FSH).